The metabolic stress of active treatment can temporarily reduce skin barrier function and melanin development, effectively lowering your natural sun resistance
For persons with sufficient ASCVD risk and type 2 diabetes, GLP-1 RAs and SGLT2 inhibitors can, and often should, be used in combination
Injectables: Which One is Better for Me
Verify that the syringes unit markings match your prescribed dosage
The most common AEs in setmelanotide-treated patients were injection-site reactions, skin hyperpigmentation, nausea, vomiting, and diarrhea
These typically manifest as localised redness, swelling, or itching at the site where the subcutaneous injection is administeredusually the abdomen, thigh, or upper arm